Medical Devices

Venture firm Sonder Capital closes its new fund with backing from Mayo Clinic and Sutter Health, aiming to revolutionize patient care with AI-powered robotics.

Biotronik launches a global study for its LivIQ system, a single-device leadless pacemaker using novel far-field sensing to restore a natural heartbeat.

With a top expert at the helm, AltaThera aims to expand its heart rhythm drug for kids, balancing life-saving potential with critical safety warnings.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

As demand for non-opioid solutions soars, OrthoLazer expands its high-tech, standardized laser therapy, aiming to redefine orthopedic wellness nationally.

Xtressé's Xvie, an injectable therapy using extracellular vesicles, has been cleared for human trials, offering new hope for androgenetic alopecia.

The expanded partnership aims to standardize care and meet soaring demand in Northwest Arkansas, integrating two new surgical facilities into the system.

LiviWell's Livi device, the first of its kind, gets FDA clearance to absorb post-sex fluids, aiming to improve comfort and vaginal health.

With 35+ years of orthopedic sales experience, Thurman Ballard joins Tetrous to drive adoption of its groundbreaking bone-to-tendon healing technology.

With new financing from Avenue Capital, Turn Therapeutics bets big on its novel skin therapy, GX-03, to tackle multi-billion dollar dermatology markets.

A new alliance between Discovery Life Sciences and Mindpeak aims to solve inconsistent biomarker interpretation, a critical bottleneck in cancer drug development.

Private equity firm Southfield Capital has acquired a majority stake in Metric Search, aiming to dominate the high-stakes recruitment market for niche talent.

Cionic's Neural Sleeve 2, a wearable AI device, has been named a top innovation for revolutionizing mobility in patients with neurological conditions.

The CRDMO giant posted a 16.7% revenue jump in 2025, driven by a massive pipeline expansion and a strategic pivot to next-generation biologics.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.

A new platform is launching to connect pharma companies directly with 70+ global regulators, promising to slash approval times and speed patient access.

A new Phase 2 trial is testing an inhaled version of a key IPF drug, aiming to reduce severe side effects and transform treatment for the fatal lung disease.

With new memberships, Prenuvo aims to standardize proactive MRI screening. Is this the future of health or a high-priced service with unproven benefits?

Global brand TENA launches reusable protective boxers, blending everyday style with advanced tech to challenge the long-held stigma of male bladder leaks.

Clarius launches T-Mode, an AI-powered training tool that demystifies heart and knee ultrasounds for frontline clinicians, promising faster diagnosis.